T43	Exp 114 116	We
T44	Exp 212 216	that
T45	Exp 260 264	that
T46	Exp 181 211	the Fas ligand (fasL) promoter
T47	Exp 589 591	us
T48	Exp 427 432	which
T49	Exp 362 378	The aberrant CD4
T50	Exp 451 460	the genes
T51	Exp 616 624	the FLRE
T52	Exp 657 681	this aberrant expression
T53	Exp 806 810	that
T54	Exp 820 828	the FLRE
T55	Exp 859 873	these proteins
T56	Exp 1275 1279	both
T57	Exp 1499 1538	the critical Egr family binding element
T58	Exp 1448 1461	this activity
R5	Coref Anaphora:T44 Antecedent:T46
R6	Coref Anaphora:T48 Antecedent:T59
R7	Coref Anaphora:T53 Antecedent:T60
T61	SPAN 470 689	Fas and FasL, respectively, have an activated phenotype and constitutively express high levels of fasL mRNA, prompting us to ask what role if any the FLRE and Egr family proteins have in this aberrant expression of fasL
R8	Coref Anaphora:T55 Antecedent:T61
T1	Protein 8 13	Egr-2
T2	Protein 34 44	Fas ligand
T3	Protein 141 151	Fas ligand
T4	Protein 185 195	Fas ligand
T5	Protein 197 201	fasL
T6	Protein 265 270	Egr-3
T7	Protein 272 277	PILOT
T8	Protein 287 292	Egr-1
T9	Protein 294 300	NGFI-A
T10	Protein 302 309	Krox-24
T11	Protein 311 316	Tis-8
T12	Protein 322 329	Zif-268
T13	Protein 356 360	fasL
T14	Protein 375 378	CD4
T15	Protein 470 473	Fas
T16	Protein 478 482	FasL
T17	Protein 568 572	fasL
T18	Protein 685 689	fasL
T19	Protein 732 735	CD4
T20	Protein 880 885	Egr-1
T21	Protein 890 895	Egr-2
T22	Protein 897 904	Krox-20
T23	Protein 907 912	Egr-3
T24	Protein 1032 1037	egr-3
T25	Protein 1053 1058	egr-2
T26	Protein 1112 1117	Egr-1
T27	Protein 1149 1154	Egr-2
T28	Protein 1172 1177	Egr-3
T29	Protein 1190 1194	fasL
T30	Protein 1304 1308	fasL
T31	Protein 1329 1333	FasL
T32	Protein 1395 1398	CD4
T33	Protein 1546 1551	Egr-2
T34	Protein 1568 1573	Egr-3
T35	Protein 1585 1589	FasL
T36	Protein 1634 1639	Egr-2
T37	Protein 1684 1688	fasL
T38	Protein 1726 1729	CD4
T59	Exp 421 425	mice
T60	Exp 793 805	two proteins
